Both in Pharmaceuticals
MBX Biosciences vs Immunome
Over the past year MBX returned +275.3% and IMNM returned +5.1%; their daily moves had a correlation of 0.25.
MBX +275.3% IMNM +5.1%Growth of $1, one year, split-adjusted
| Metric | MBX | IMNM |
|---|---|---|
| Price | $49.61 | $16.47 |
| Market cap | $2.39B | $1.94B |
| Today | −2.17% | −5.34% |
| 1 month | −22.4% | −31.2% |
| 6 months | +46.9% | −33.1% |
| Year to date | +57.3% | −23.3% |
| 1 year | +255.6% | +0.7% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $520.0M |
| Dividend yield | — | — |
| Volatility (60d) | 48.9% | 56.2% |
| Short % of float | 15.2% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).